These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 1549953)
1. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro. Marie PJ; De Vernejoul MC; Lomri A J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953 [TBL] [Abstract][Full Text] [Related]
2. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. Marie PJ; de Vernejoul MC; Connes D; Hott M J Clin Invest; 1991 Oct; 88(4):1167-72. PubMed ID: 1918371 [TBL] [Abstract][Full Text] [Related]
3. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). De Pollack C; Renier D; Hott M; Marie PJ J Bone Miner Res; 1996 Mar; 11(3):401-7. PubMed ID: 8852951 [TBL] [Abstract][Full Text] [Related]
4. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria. de Pollak C; Arnaud E; Renier D; Marie PJ J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761 [TBL] [Abstract][Full Text] [Related]
5. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women. Lomri A; Marie PJ J Bone Miner Res; 1990 Nov; 5(11):1149-55. PubMed ID: 2176773 [TBL] [Abstract][Full Text] [Related]
6. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. Marie PJ; Sabbagh A; de Vernejoul MC; Lomri A J Clin Endocrinol Metab; 1989 Aug; 69(2):272-9. PubMed ID: 2787799 [TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular effects of growth hormone and estrogen on human bone cells. Kassem M APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells. Takada J; Baylink DJ; Lau KH J Bone Miner Res; 1995 Oct; 10(10):1512-22. PubMed ID: 8686507 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687 [TBL] [Abstract][Full Text] [Related]
10. Effect of fluoride on bone and bone cells in ovariectomized rats. Modrowski D; Miravet L; Feuga M; Bannié F; Marie PJ J Bone Miner Res; 1992 Aug; 7(8):961-9. PubMed ID: 1442210 [TBL] [Abstract][Full Text] [Related]
11. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3. Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311 [TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies. Sterck JG; Klein-Nulend J; Burger EH; Lips P J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947 [TBL] [Abstract][Full Text] [Related]
13. In vitro exposure to sodium fluoride does not modify activity or proliferation of human osteoblastic cells in primary cultures. Chavassieux P; Chenu C; Valentin-Opran A; Delmas PD; Boivin G; Chapuy MC; Meunier PJ J Bone Miner Res; 1993 Jan; 8(1):37-44. PubMed ID: 8427047 [TBL] [Abstract][Full Text] [Related]
14. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta. Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854 [TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. Fromigué O; Marie PJ; Lomri A J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905 [TBL] [Abstract][Full Text] [Related]
16. Fluoride modification effects on osteoblast behavior and bone formation at TiO2 grit-blasted c.p. titanium endosseous implants. Cooper LF; Zhou Y; Takebe J; Guo J; Abron A; Holmén A; Ellingsen JE Biomaterials; 2006 Feb; 27(6):926-36. PubMed ID: 16112191 [TBL] [Abstract][Full Text] [Related]
17. Osteoblast dysfunction in male idiopathic osteoporosis. Pernow Y; Granberg B; Sääf M; Weidenhielm L Calcif Tissue Int; 2006 Feb; 78(2):90-7. PubMed ID: 16467976 [TBL] [Abstract][Full Text] [Related]
18. Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells. Dean DD; Schwartz Z; Blanchard CR; Liu Y; Agrawal CM; Lohmann CH; Sylvia VL; Boyan BD J Orthop Res; 1999 Jan; 17(1):9-17. PubMed ID: 10073642 [TBL] [Abstract][Full Text] [Related]
19. Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption. Lau KH; Wang SP; Linkhart TA; Demarest KT; Baylink DJ J Bone Miner Res; 1994 May; 9(5):695-703. PubMed ID: 8053399 [TBL] [Abstract][Full Text] [Related]
20. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Marie PJ; de Pollak C; Chanson P; Lomri A Am J Pathol; 1997 Mar; 150(3):1059-69. PubMed ID: 9060842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]